Fundz

Sage Therapeutics, Inc. reported raising $650 Million in an initial SEC Form D filing, from an offering of $650 Million

RECENTLY ACQUIREDJan 15, 2021

Amount Raised

$650 Million

$650 Million sold, per SEC Form D (first sale Jan 15, 2021)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

SAGE Therapeutics raised $650 Million in a funding round, dated January 15, 2021. SAGE Therapeutics is based in Cambridge, Massachusetts, United States.

How much did SAGE Therapeutics raise?
SAGE Therapeutics raised $650 Million in a funding round on January 15, 2021.
What does SAGE Therapeutics do?
SAGE Therapeutics, Inc. is a biotechnology company dedicated to developing therapies for central nervous system disorders.
Where is SAGE Therapeutics based and how big is it?
SAGE Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 180 employees.
Who are the decision-makers at SAGE Therapeutics?
Fundz holds 2 contacts at SAGE Therapeutics, including the Vice President, Head of Clinical Development Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as SAGE Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $14M on February 16, 2021.
  • Design Therapeutics, Inc. raised $125M on February 12, 2021.
  • ISOThrive raised $5.2M on February 5, 2021.
  • Design Therapeutics, Inc. raised $125M (Series B) on January 27, 2021.
  • Zevra Therapeutics, Inc. raised $31M on January 13, 2021.
  • Werewolf Therapeutics raised $72M on January 7, 2021.

Who to call at SAGE Therapeutics, and when

A new round usually means SAGE Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SAGE Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SAGE Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SAGE Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SAGE Therapeutics

Location

Cambridge, Massachusetts, United States

About

SAGE Therapeutics, Inc. is a biotechnology company dedicated to developing therapies for central nervous system disorders. Its key product, Zurzuvae, targets postpartum depression. The company was previously independently traded on the Nasdaq.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SAGE Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMollie B., Vice President, Head of Clinical Develo… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SAGE Therapeutics's next move

See what Strategic adds

SAGE Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.